Tetrahydropalmatine alleviated diabetic neuropathic pain by inhibiting activation of microglia via p38 MAPK signaling pathway.
10.19540/j.cnki.cjcmm.20220119.702
- Author:
Lian-Zhi CHENG
1
;
Jia-Mei ZHOU
1
;
Jun-Long MA
1
;
Fan-Jing WANG
1
;
Kai CHENG
1
;
Qian CHEN
1
;
Hui-Lun YUAN
1
;
Ai-Juan JIANG
2
Author Information
1. School of Integrated Traditional Chinese and Western Medicine, Anhui University of Traditonal Chinese Medicine Hefei 230012, China.
2. School of Integrated Traditional Chinese and Western Medicine, Anhui University of Traditonal Chinese Medicine Hefei 230012, China Institute of Integrated Traditional Chinese and Western Medicine, Anhui Academy of Chinese Medicine Hefei 230012, China.
- Publication Type:Journal Article
- Keywords:
BV2 microglia;
M1/M2 polarization;
diabetic neuropathic pain;
inflammation;
p38 MAPK singling pathway;
tetrahydropalmatine
- MeSH:
Animals;
Berberine Alkaloids;
Blood Glucose/metabolism*;
Diabetes Mellitus;
Diabetic Neuropathies/genetics*;
Interleukin-10;
Interleukin-6/metabolism*;
Lipopolysaccharides/pharmacology*;
Microglia;
Neuralgia/metabolism*;
Rats;
Rats, Sprague-Dawley;
Signal Transduction;
Spinal Cord/metabolism*;
Streptozocin/therapeutic use*;
Tumor Necrosis Factor-alpha/metabolism*;
p38 Mitogen-Activated Protein Kinases/metabolism*
- From:
China Journal of Chinese Materia Medica
2022;47(9):2533-2540
- CountryChina
- Language:Chinese
-
Abstract:
Neuropathic pain is one of the common complications of diabetes. Tetrahydropalmatine(THP) is a main active component of Corydalis Rhizoma with excellent anti-inflammatory and pain-alleviating properties. This study aims to investigate the therapeutic effect of THP on diabetic neuropathic pain(DNP) and the underlying mechanism. High-fat and high-sugar diet(4 weeks) and streptozotocin(STZ, 35 mg·kg~(-1), single intraperitoneal injection) were employed to induce type-2 DNP in rats. Moreover, lipopolysaccharide(LPS) was used to induce the activation of BV2 microglia in vitro to establish an inflammatory cellular model. Fasting blood glucose(FBG) was measured by a blood glucose meter. Mechanical withdrawal threshold(MWT) was assessed with von Frey filaments, and thermal withdrawal latency(TWL) with hot plate apparatus. The protein expression levels of OX42, inducible nitric oxide synthase(iNOS), CD206, p38, and p-p38 were determined by Western blot, the fluorescence expression levels of OX42 and p-p38 in the dorsal horn of the rat spinal cord by immunofluorescence, the mRNA content of p38 and OX42 in rat spinal cord tissue by qRT-PCR, and levels of nitric oxide(NO), interleukin-1β(IL-1β), interleukin-6(IL-6), tumor necrosis factor-α(TNF-α), interleukin-10(IL-10), and serum fasting insulin(FINS) by enzyme-linked immunosorbent assay(ELISA). RESULTS:: showed that the mo-del group demonstrated significant decrease in MWT and TWL, with pain symptoms. THP significantly improved the MWT and TWL of DNP rats, inhibited the activation of microglia and p38 MAPK signaling pathway in rat spinal cord, and ameliorated its inflammatory response. Meanwhile, THP promoted the change of LPS-induced BV2 microglia from the pro-inflammatory M1 phenotype to the anti-inflammatory M2 phenotype, suppressed the activation of the p38 MAPK signaling pathway, decreased the expression levels of inflammatory factors NO, IL-1β, IL-6, and TNF-α, and increased the expression level of anti-inflammatory factor IL-10. The findings suggested that THP can significantly ameliorate the pain symptoms of DNP rats possibly by inhibiting the inflammatory response caused by M1 polarization of microglia via the p38 MAPK pathway.
